caselaw.findlaw.com/us-1st-circuit/1102488.html

Case opinion for US 1st Circuit CARNERO v. BOSTON SCIENTIFIC CORPORATION. Read the Court's full decision on FindLaw.

news.bostonscientific.com/2018-09-06-Boston-Scientific-Announces-Agreement-To-Acquire-Augmenix-Inc

Sep 6, 2018 ... Boston Scientific Corporation (PRNewsFoto/Boston Scientific Corporation) ... All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further list ... 1 Ferlay JSI, et al.

news.bostonscientific.com/2018-04-16-Boston-Scientific-Prevails-In-European-Patent-Dispute-With-Edwards-Lifesciences

Apr 16, 2018 ... The company is also seeking CE mark application for the next-generation transcatheter ... All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. ... iii Abdel-Wahab M et al.

news.bostonscientific.com/2017-03-09-Boston-Scientific-Receives-Favorable-Rulings-In-Edwards-Lifesciences-Litigation

Mar 9, 2017 ... Each company has opposed the other's patents in the EPO. This decision in ... All of these factors are difficult or impossible to predict accurately and many of them are beyond our control. For a further ... iii Abdel-Wahab M et al.

news.bostonscientific.com/2018-08-02-Boston-Scientific-Closes-Acquisition-of-Claret-Medical-Inc-Announces-Positive-Reimbursement-Decision

Aug 2, 2018 ... 2, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announced it ... Embolic debris such as calcium or tissue can break loose during the procedure, ... 2 Webb, et al., J Am Coll Cardiol Intv. 2015;8:1797-1806.